LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Sustained Liver HBsAg Loss and Clonal T- and B-Cell Expansion upon Therapeutic DNA Vaccination Require Low HBsAg Levels.

Conceição-Neto, Nádia / Pierson, Wim / Vacca, Maurizio / Beyens, Matthias / De Clerck, Ben / Aerts, Liese / Voeten, Birgit / De Pooter, Dorien / Verschueren, Lore / Dockx, Koen / Vandenberk, Mathias / De Troyer, Ewoud / Verwilt, Kato / Van Hove, Carl / Verslegers, Mieke / Bosseler, Leslie / Crabbe, Marjolein / Krishna, Vinod / Nájera, Isabel /
Van Gulck, Ellen

Vaccines

2023  Volume 11, Issue 12

Abstract: Background: Suppression of HBV DNA, inhibition of HBV surface (HBsAg) production and therapeutic vaccination to reverse HBV-specific T-cell exhaustion in chronic HBV patients are likely required to achieve a functional cure. In the AAV-HBV mouse model, ... ...

Abstract Background: Suppression of HBV DNA, inhibition of HBV surface (HBsAg) production and therapeutic vaccination to reverse HBV-specific T-cell exhaustion in chronic HBV patients are likely required to achieve a functional cure. In the AAV-HBV mouse model, therapeutic vaccination can be effective in clearing HBV when HBsAg levels are low. Using a single-cell approach, we investigated the liver immune environment with different levels of HBsAg and sustained HBsAg loss through treatment with a GalNAc-HBV-siRNA followed by therapeutic vaccination.
Methods: AAV-HBV-transduced C57BL/6 mice were treated with GalNAc-HBV-siRNA to lower HBsAg levels and then vaccinated using a DNA vaccine. We used single-cell RNA and V(D)J sequencing to understand liver immune microenvironment changes.
Results: GalNAc-HBV-siRNA, followed by therapeutic vaccination, achieved sustained HBsAg loss in all mice. This was accompanied by CD4 follicular helper T-cell induction, polyclonal activation of CD8 T cells and clonal expansion of plasma cells that were responsible for antibody production.
Conclusions: This study provides novel insights into liver immune changes at the single-cell level, highlighting the correlation between induced reduction of HBsAg levels and clonal expansion of CD4, CD8 T cells and plasma cells in the liver upon HBV siRNA and subsequent therapeutic vaccination.
Language English
Publishing date 2023-12-06
Publishing country Switzerland
Document type Journal Article
ZDB-ID 2703319-3
ISSN 2076-393X
ISSN 2076-393X
DOI 10.3390/vaccines11121825
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top